These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7464303)

  • 1. Documenting outpatient problem intervention activities of pharmacists in an HMO.
    Christensen DB; Campbell WH; Madsen S; Hartzema AG; Nudelman PM
    Med Care; 1981 Jan; 19(1):104-17. PubMed ID: 7464303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and clarification of drug therapy problems by Indian health service pharmacists.
    Smith CP; Christensen DB
    Ann Pharmacother; 1996 Feb; 30(2):119-24. PubMed ID: 8835041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting.
    Christensen DB; Hansen RW
    J Am Pharm Assoc (Wash); 1999; 39(5):640-9. PubMed ID: 10533345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug related problems in Belgian community pharmacies].
    Huysmans K; De Wulf I; Foulon V; De Loof H; Steurbaut S; Boussery K; De Vriese C; Lacour V; Van Hees T; De Meyer GR
    J Pharm Belg; 2014 Mar; (1):4-15. PubMed ID: 24804389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
    Desmaele S; De Wulf I; Dupont AG; Steurbaut S
    Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
    Christensen DB; Roth M; Trygstad T; Byrd J
    J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of drug counseling and other educational strategies on drug utilization of the elderly.
    Hammarlund ER; Ostrom JR; Kethley AJ
    Med Care; 1985 Feb; 23(2):165-70. PubMed ID: 3974333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacist interventions in a capitated pharmacy benefit contract.
    Knapp KK; Katzman H; Hambright JS; Albrant DH
    Am J Health Syst Pharm; 1998 Jun; 55(11):1141-5. PubMed ID: 9626376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.
    Garada M; McLachlan AJ; Schiff GD; Lehnbom EC
    BMC Health Serv Res; 2017 Nov; 17(1):734. PubMed ID: 29141618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of concentration ratios to analyze the phenomenon of "next-door" pharmacy in Taiwan.
    Ji Chen T; Chou LF; Hwang SJ
    Clin Ther; 2006 Aug; 28(8):1225-1230. PubMed ID: 16982300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clinical pharmacists on drug prescribing in a primary-care clinic.
    Stergachis A; Fors M; Wagner EH; Sims DD; Penna P
    Am J Hosp Pharm; 1987 Mar; 44(3):525-9. PubMed ID: 3565410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist time requirements for counseling in an outpatient pharmacy.
    Oh Y; McCombs JS; Cheng RA; Johnson KA
    Am J Health Syst Pharm; 2002 Dec; 59(23):2346-55. PubMed ID: 12489376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists help HMO cut drug costs.
    Knowlton CH; Knapp DA
    Am Pharm; 1994 Jan; NS34(1):36-42. PubMed ID: 8166034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing problems and pharmacist interventions in community practice.
    Rupp MT; DeYoung M; Schondelmeyer SW
    Med Care; 1992 Oct; 30(10):926-40. PubMed ID: 1405798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient anti-epileptic drug prescribing errors in a Children's Hospital: an audit and literature review.
    Murphy AP; Bentur H; Dolan C; Bugembe T; Gill A; Appleton R
    Seizure; 2014 Oct; 23(9):786-91. PubMed ID: 25023722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.